Showing results (81-90 of 3,787) with videos related to
Sort By:
Pageof 379
Oncoimmunology|January 9, 2018
Blockade of PD-1 effectively inhibits in vivo malignant transformation of oral mucosaYichen Chen, Qiusheng Li, Xinye Li, et al.Oncoimmunology|January 9, 2018
High numbers of PDCD1 (PD-1)-positive T cells and B2M mutations in microsatellite-unstable colorectal cancerJonas Janikovits, Meike Müller, Julia Krzykalla, et al.Oncoimmunology|January 9, 2018
Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitorsSheila López-Cobo, Natalia Pieper, Carmen Campos-Silva, et al.Oncoimmunology|February 9, 2018
Tumor-associated macrophages remodeling EMT and predicting survival in colorectal carcinomaSi Li, Fangying Xu, Jing Zhang, et al.Oncoimmunology|February 24, 2018
CorrigendumOncoimmunology|January 30, 2018
Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)Ricarda M Hoffmann, Ben G T Coumbe, Debra H Josephs, et al.Oncoimmunology|April 9, 2016
Phenotype, development, and biological function of myeloid-derived suppressor cellsYang Zhao, Tingting Wu, Steven Shao, et al.Oncoimmunology|April 9, 2016
Tumor vaccines with dsRNA adjuvant ARNAX induces antigen-specific tumor shrinkage without cytokinemiaTsukasa Seya, Yohei Takeda, Misako MatsumotoOncoimmunology|April 9, 2016
Resistance is futile: Targeting the inhibitory FcγRIIB (CD32B) to maximize immunotherapyAli Roghanian, Mark S Cragg, Björn FrendéusOncoimmunology|April 9, 2016
Breaking bad habits: Targeting MDSCs to alleviate immunosuppression in prostate cancerSumanta K Pal, Marcin KortylewskiPageof 379